» Articles » PMID: 21151726

Malignant Phyllodes Tumour with Liposarcomatous Differentiation, Invasive Tubular Carcinoma, and Ductal and Lobular Carcinoma in Situ: Case Report and Review of the Literature

Overview
Publisher Hindawi
Specialty Pathology
Date 2010 Dec 15
PMID 21151726
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A 43-year-old woman presented with a right breast lump that had enlarged over 5 months. She had chemoradiotherapy for non-Hodgkin's lymphoma in 1989. Histology revealed a malignant phyllodes tumour (PT) with liposarcomatous differentiation and ductal carcinoma in situ (DCIS) within the tumour with invasive tubular carcinoma, DCIS, and lobular carcinoma in situ in the surrounding breast. She had surgery and adjuvant radiotherapy. One year follow-up showed no recurrence or metastatic disease. Liposarcomatous differentiation is uncommon in PTs, and coexisting carcinoma is rare with 38 cases in 31 reports in the literature. Carcinoma is reported in malignant (n = 19), benign (n = 16) and in borderline PTs (n = 3) with invasive carcinoma (n = 18) and pure in situ carcinoma (n = 19) recorded in equal frequency. Carcinoma is more commonly found within the confines of benign PTs; whereas it is more often found surrounding the PT or in the contralateral breast in malignant PTs. Previous radiotherapy treatment is reported in only two cases. The aetiology of co-existing carcinoma is unclear but the rarity of previous radiotherapy treatment suggests that it is incidental. This case highlights the diverse pathology that can occur with PTs, which should be considered when evaluating pathology specimens as they may impact on patient management.

Citing Articles

Infiltrating lobular carcinoma of LUMB HER2+ subtype with rhabdoid feature coexisting with synchronous malignant transformation of phyllodes tumor: An exceedingly rare clinicopathological characteristic in Vietnam.

Do T, Mai N, Nguyen D, Pham K, Le D, Van Pham H Rare Tumors. 2024; 16:20363613241271665.

PMID: 39108547 PMC: 11301723. DOI: 10.1177/20363613241271665.


Co-existence of malignant phylloid tumor and metaplastic malignant spindle cell carcinoma: case report.

Jamjoum G, Alrefaei M, Alhamed W, Alsefri J, Abuzinadah A J Surg Case Rep. 2024; 2024(7):rjae465.

PMID: 39056023 PMC: 11272168. DOI: 10.1093/jscr/rjae465.


Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.

Chen J, Zhu I, Patel A, Krings G, Chen Y, Yuen F Adv Radiat Oncol. 2024; 9(5):101448.

PMID: 38550370 PMC: 10965428. DOI: 10.1016/j.adro.2024.101448.


A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts.

Li C, Zhang C Medicine (Baltimore). 2023; 102(48):e36405.

PMID: 38050272 PMC: 10695601. DOI: 10.1097/MD.0000000000036405.


Unexpectedly High Coexistence Rate of /Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study.

Gemci O, Altinay S, Ilbar Tartar R, Ferahman S Eur J Breast Health. 2022; 18(4):343-352.

PMID: 36248757 PMC: 9521284. DOI: 10.4274/ejbh.galenos.2022.2022-6-2.


References
1.
Powell C, Rosen P . Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol. 1994; 18(7):720-7. DOI: 10.1097/00000478-199407000-00008. View

2.
De Rosa G, Ferrara G, Goglia P, Ghicas C, Zeppa P . In situ and microinvasive carcinoma with squamoid differentiation arising in a phyllodes tumor: report of a case. Tumori. 1989; 75(5):514-7. DOI: 10.1177/030089168907500525. View

3.
Parfitt J, Armstrong C, OMalley F, Ross J, Tuck A . In-situ and invasive carcinoma within a phyllodes tumor associated with lymph node metastases. World J Surg Oncol. 2004; 2:46. PMC: 545046. DOI: 10.1186/1477-7819-2-46. View

4.
Page D, Ellis I, Elston C . Histologic grading of breast cancer. Let's do it. Am J Clin Pathol. 1995; 103(2):123-4. DOI: 10.1093/ajcp/103.2.123. View

5.
Merck B, Cansado Martinez P, Perez Ramos M, Martinez Banaclocha N, Lacueva Gomez F, Calpena R . Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches. Clin Transl Oncol. 2006; 8(11):830-2. DOI: 10.1007/s12094-006-0140-7. View